IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Emcure Pharmaceuticals IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 1952.03 Cr. The company is based in Pune and caters to Pharmaceutical sector. Axis Capital , J.P. Morgan India , Jefferies India , Kotak Mahindra Capital Company are the merchant bankers of Emcure Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th December 2023.
Emcure Pharmaceuticals IPO posted revenues of ₹ 6715.24 crores and PAT of ₹ 527.58 crores in FY25 on annualised basis.
Revenue:
₹ 6,658.25 Cr.
EBITDA Margin:
19.18
% 
Net Worth: ₹ 3121.77 Cr.
Market Capitalisation:
₹ 19029.89 Cr.
P/E:
36.07 times
P/BV: 3.75 times
EV/EBITDA: 16.41 times
Financial results of Emcure Pharmaceuticals IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY24 | FY23 | FY22 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 7806.16 | 6672.53 | 6063.47 | ||
| Net Worth | 3121.77 | 2649.66 | 2114.14 | ||
| Total Debt | 2087.31 | 2194.93 | 2083.63 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
6658.25 | 5985.81 | 5855.39 | ||
EBITDA
EBITDA on annualised basis |
1276.78 | 1220.94 | 1393.38 | ||
PAT
PAT on annualised basis |
527.58 | 561.85 | 702.56 | ||
Emcure Pharmaceuticals IPO PAT Margin is 7.92 % , ROCE (Return on Capital Employed) is 19.37 % as per latest financial. The below table shows Emcure Pharmaceuticals IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY24 | FY23 | FY22 |
|---|---|---|---|
| EBITDA Margin (%) | 19.18 | 20.40 | 23.80 |
| PAT Margin (%) | 7.92 | 9.39 | 12.00 |
| EPS (₹) | 27.54 | 29.42 | 27.54 |
| ROE (%) | 16.90 | 21.20 | 33.23 |
| ROCE (%) | 19.37 | 22.01 | 29.69 |
| ROA (%) | 6.76 | 8.42 | 11.59 |
| Debt to Equity | 0.67 | 0.83 | 0.99 |
The market Capitalisation of Emcure Pharmaceuticals IPO is ₹ 19029.89 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Emcure Pharmaceuticals IPO prospectus highlights an Return on Equity (ROE) of 16.90 % , Return on Assets (ROA) of 6.76 %, and an EBITDA Margin of 19.18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Emcure Pharmaceuticals IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Emcure Pharmaceuticals IPO is ₹ 19029.89 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Emcure Pharmaceuticals IPO has a Price-to-Earnings (PE) ratio of 36.07 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Emcure Pharmaceuticals IPO reported revenue of ₹ 6715.24 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Emcure Pharmaceuticals IPO provide insights into sales growth, market demand, and business scalability.
Emcure Pharmaceuticals recorded an EBITDA of ₹ 1,276.78 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Emcure Pharmaceuticals Profit After Tax (PAT) is ₹ 527.58 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 6,658.25 Cr.
EBITDA Margin:
19.18
%
Net Worth: ₹ 3121.77 Cr.
Market Capitalisation:
₹ 19029.89 Cr.
P/E:
36.07 times
P/BV: 3.75 times
EV/EBITDA: 16.41 times
Emcure Pharmaceuticals operates in Pharmaceutical and Broad Range Of Pharma. The Issue is listed on BSE,NSE in Jul, 2024. Emcure Pharmaceuticals IPO size was 1952.03 with Issue price of 1008.00 .
Merchant Banker(s) of Emcure Pharmaceuticals IPO: Axis Capital Limited , J.P. Morgan India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Emcure Pharmaceuticals IPO subscription was 67.87 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Emcure Pharmaceuticals IPO listed at a listing price of 1358.85 against the offer price of 1008.00.
The current market price of Emcure Pharmaceuticals is 1318.40.
Why Us?
